APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

GLP Analogs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GLP Analogs Market Outlook and Growth Opportunities 2026

Report ID 17399545042 January 2026192 pages

Choose your research edition.

Industry ResearchGLP Analogs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP Analogs Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal GLP Analogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP Analogs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP Analogs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global GLP Analogs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GLP Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GLP Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GLP Analogs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GLP Analogs market include Sanofi, Eli Lily, GSK, AstraZeneca, Novo Nordisk, Bristol-Myers Squibb and Amylin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GLP Analogs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GLP Analogs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GLP Analogs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GLP Analogs market size, projected growth trends, production technologies, key applications, and end-use industries.

GLP Analogs Segment by Company

Sanofi

Eli Lily

GSK

AstraZeneca

Novo Nordisk

Bristol-Myers Squibb

Amylin

GLP Analogs Segment by Type

Albiglutide

Exenatied

Dulaglutide

Liraglutide

Lixisenatide

GLP Analogs Segment by Application

Hospital

Pharmacy

Other

GLP Analogs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global GLP Analogs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GLP Analogs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GLP Analogs significant trends, drivers, influence factors in global and regions.

6. To analyze GLP Analogs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP Analogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP Analogs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP Analogs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GLP Analogs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GLP Analogs industry.

Chapter 3: Detailed analysis of GLP Analogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GLP Analogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GLP Analogs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GLP Analogs Industry Trends Table 2. GLP Analogs Industry Drivers Table 3. GLP Analogs Industry Opportunities and Challenges Table 4. GLP Analogs Industry Restraints Table 5. Global GLP Analogs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GLP Analogs Revenue Share by Company (2021-2026) Table 7. Global GLP Analogs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global GLP Analogs Sales Volume Share by Company (2021-2026) Table 9. Global GLP Analogs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global GLP Analogs Company Ranking, (2024-2026) & (USD Million) Table 11. Global GLP Analogs Key Company Manufacturing Base & Headquarters Table 12. Global GLP Analogs Company, Product Type & Application Table 13. Global GLP Analogs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GLP Analogs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Albiglutide Table 18. Significant Companies of Exenatied Table 19. Significant Companies of Dulaglutide Table 20. Significant Companies of Liraglutide Table 21. Significant Companies of Lixisenatide Table 22. Global GLP Analogs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global GLP Analogs Sales Volume by Type (2021-2026) & (K Units) Table 24. Global GLP Analogs Sales Volume by Type (2027-2032) & (K Units) Table 25. Global GLP Analogs Sales Volume Share by Type (2021-2026) Table 26. Global GLP Analogs Sales Volume Share by Type (2027-2032) Table 27. Global GLP Analogs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global GLP Analogs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global GLP Analogs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global GLP Analogs Sales Value Share by Type (2021-2026) Table 31. Global GLP Analogs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Pharmacy Table 34. Significant Companies of Other Table 35. Global GLP Analogs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global GLP Analogs Sales Volume by Application (2021-2026) & (K Units) Table 37. Global GLP Analogs Sales Volume by Application (2027-2032) & (K Units) Table 38. Global GLP Analogs Sales Volume Share by Application (2021-2026) Table 39. Global GLP Analogs Sales Volume Share by Application (2027-2032) Table 40. Global GLP Analogs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global GLP Analogs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global GLP Analogs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global GLP Analogs Sales Value Share by Application (2021-2026) Table 44. Global GLP Analogs Sales Value Share by Application (2027-2032) Table 45. Global GLP Analogs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global GLP Analogs Sales by Region (2021-2026) & (K Units) Table 47. Global GLP Analogs Sales Market Share by Region (2021-2026) Table 48. Global GLP Analogs Sales by Region (2027-2032) & (K Units) Table 49. Global GLP Analogs Sales Market Share by Region (2027-2032) Table 50. Global GLP Analogs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global GLP Analogs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global GLP Analogs Sales Value Share by Region (2021-2026) Table 53. Global GLP Analogs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global GLP Analogs Sales Value Share by Region (2027-2032) Table 55. Global GLP Analogs Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global GLP Analogs Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global GLP Analogs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global GLP Analogs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global GLP Analogs Sales by Country (2021-2026) & (K Units) Table 60. Global GLP Analogs Sales Market Share by Country (2021-2026) Table 61. Global GLP Analogs Sales by Country (2027-2032) & (K Units) Table 62. Global GLP Analogs Sales Market Share by Country (2027-2032) Table 63. Global GLP Analogs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global GLP Analogs Sales Value Market Share by Country (2021-2026) Table 65. Global GLP Analogs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global GLP Analogs Sales Value Market Share by Country (2027-2032) Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi GLP Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sanofi GLP Analogs Product Portfolio Table 71. Sanofi Recent Development Table 72. Eli Lily Company Information Table 73. Eli Lily Business Overview Table 74. Eli Lily GLP Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eli Lily GLP Analogs Product Portfolio Table 76. Eli Lily Recent Development Table 77. GSK Company Information Table 78. GSK Business Overview Table 79. GSK GLP Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. GSK GLP Analogs Product Portfolio Table 81. GSK Recent Development Table 82. AstraZeneca Company Information Table 83. AstraZeneca Business Overview Table 84. AstraZeneca GLP Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. AstraZeneca GLP Analogs Product Portfolio Table 86. AstraZeneca Recent Development Table 87. Novo Nordisk Company Information Table 88. Novo Nordisk Business Overview Table 89. Novo Nordisk GLP Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Novo Nordisk GLP Analogs Product Portfolio Table 91. Novo Nordisk Recent Development Table 92. Bristol-Myers Squibb Company Information Table 93. Bristol-Myers Squibb Business Overview Table 94. Bristol-Myers Squibb GLP Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Bristol-Myers Squibb GLP Analogs Product Portfolio Table 96. Bristol-Myers Squibb Recent Development Table 97. Amylin Company Information Table 98. Amylin Business Overview Table 99. Amylin GLP Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Amylin GLP Analogs Product Portfolio Table 101. Amylin Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. GLP Analogs Distributors List Table 105. GLP Analogs Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. GLP Analogs Product Image Figure 2. Global GLP Analogs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP Analogs Sales Value (2021-2032) & (US$ Million) Figure 4. Global GLP Analogs Sales (2021-2032) & (K Units) Figure 5. Global GLP Analogs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global GLP Analogs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Albiglutide Image Figure 10. Exenatied Image Figure 11. Dulaglutide Image Figure 12. Liraglutide Image Figure 13. Lixisenatide Image Figure 14. Global GLP Analogs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global GLP Analogs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global GLP Analogs Sales Volume Share by Type (2021-2032) Figure 17. Global GLP Analogs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global GLP Analogs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global GLP Analogs Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Pharmacy Image Figure 22. Other Image Figure 23. Global GLP Analogs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global GLP Analogs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global GLP Analogs Sales Volume Share by Application (2021-2032) Figure 26. Global GLP Analogs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global GLP Analogs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global GLP Analogs Sales Value Share by Application (2021-2032) Figure 29. Global GLP Analogs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global GLP Analogs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global GLP Analogs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global GLP Analogs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America GLP Analogs Sales Value (2021-2032) & (US$ Million) Figure 34. North America GLP Analogs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe GLP Analogs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe GLP Analogs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific GLP Analogs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific GLP Analogs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America GLP Analogs Sales Value (2021-2032) & (US$ Million) Figure 40. South America GLP Analogs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa GLP Analogs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa GLP Analogs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt GLP Analogs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt GLP Analogs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt GLP Analogs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. GLP Analogs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. GLP Analogs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Albiglutide
  • Exenatied
  • Dulaglutide
  • Liraglutide
  • Lixisenatide
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Sanofi
  • Eli Lily
  • GSK
  • AstraZeneca
  • Novo Nordisk
  • Bristol-Myers Squibb
  • Amylin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GLP Analogs Sales Value (2021-2032)
  4. 1.2.2 Global GLP Analogs Sales Volume (2021-2032)
  5. 1.2.3 Global GLP Analogs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GLP Analogs Market Dynamics
  1. 2.1 GLP Analogs Industry Trends
  2. 2.2 GLP Analogs Industry Drivers
  3. 2.3 GLP Analogs Industry Opportunities and Challenges
  4. 2.4 GLP Analogs Industry Restraints
3 GLP Analogs Market by Company
  1. 3.1 Global GLP Analogs Company Revenue Ranking in 2025
  2. 3.2 Global GLP Analogs Revenue by Company (2021-2026)
  3. 3.3 Global GLP Analogs Sales Volume by Company (2021-2026)
  4. 3.4 Global GLP Analogs Average Price by Company (2021-2026)
  5. 3.5 Global GLP Analogs Company Ranking (2024-2026)
  6. 3.6 Global GLP Analogs Company Manufacturing Base and Headquarters
  7. 3.7 Global GLP Analogs Company Product Type and Application
  8. 3.8 Global GLP Analogs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GLP Analogs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GLP Analogs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GLP Analogs Market by Type
  1. 4.1 GLP Analogs Type Introduction
  2. 4.1.1 Albiglutide
  3. 4.1.2 Exenatied
  4. 4.1.3 Dulaglutide
  5. 4.1.4 Liraglutide
  6. 4.1.5 Lixisenatide
  7. 4.2 Global GLP Analogs Sales Volume by Type
  8. 4.2.1 Global GLP Analogs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global GLP Analogs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global GLP Analogs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global GLP Analogs Sales Value by Type
  12. 4.3.1 Global GLP Analogs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global GLP Analogs Sales Value by Type (2021-2032)
  14. 4.3.3 Global GLP Analogs Sales Value Share by Type (2021-2032)
5 GLP Analogs Market by Application
  1. 5.1 GLP Analogs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global GLP Analogs Sales Volume by Application
  6. 5.2.1 Global GLP Analogs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GLP Analogs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global GLP Analogs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global GLP Analogs Sales Value by Application
  10. 5.3.1 Global GLP Analogs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global GLP Analogs Sales Value by Application (2021-2032)
  12. 5.3.3 Global GLP Analogs Sales Value Share by Application (2021-2032)
6 GLP Analogs Regional Sales and Value Analysis
  1. 6.1 Global GLP Analogs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GLP Analogs Sales by Region (2021-2032)
  3. 6.2.1 Global GLP Analogs Sales by Region: 2021-2026
  4. 6.2.2 Global GLP Analogs Sales by Region (2027-2032)
  5. 6.3 Global GLP Analogs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GLP Analogs Sales Value by Region (2021-2032)
  7. 6.4.1 Global GLP Analogs Sales Value by Region: 2021-2026
  8. 6.4.2 Global GLP Analogs Sales Value by Region (2027-2032)
  9. 6.5 Global GLP Analogs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GLP Analogs Sales Value (2021-2032)
  12. 6.6.2 North America GLP Analogs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GLP Analogs Sales Value (2021-2032)
  15. 6.7.2 Europe GLP Analogs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GLP Analogs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GLP Analogs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GLP Analogs Sales Value (2021-2032)
  21. 6.9.2 South America GLP Analogs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GLP Analogs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GLP Analogs Sales Value Share by Country, 2025 VS 2032
7 GLP Analogs Country-level Sales and Value Analysis
  1. 7.1 Global GLP Analogs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GLP Analogs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GLP Analogs Sales by Country (2021-2032)
  4. 7.3.1 Global GLP Analogs Sales by Country (2021-2026)
  5. 7.3.2 Global GLP Analogs Sales by Country (2027-2032)
  6. 7.4 Global GLP Analogs Sales Value by Country (2021-2032)
  7. 7.4.1 Global GLP Analogs Sales Value by Country (2021-2026)
  8. 7.4.2 Global GLP Analogs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GLP Analogs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GLP Analogs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GLP Analogs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GLP Analogs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GLP Analogs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GLP Analogs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GLP Analogs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GLP Analogs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GLP Analogs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GLP Analogs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GLP Analogs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GLP Analogs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GLP Analogs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GLP Analogs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GLP Analogs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GLP Analogs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GLP Analogs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GLP Analogs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GLP Analogs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GLP Analogs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GLP Analogs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GLP Analogs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GLP Analogs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GLP Analogs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GLP Analogs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GLP Analogs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GLP Analogs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GLP Analogs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GLP Analogs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GLP Analogs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GLP Analogs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GLP Analogs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GLP Analogs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GLP Analogs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GLP Analogs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GLP Analogs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GLP Analogs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GLP Analogs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GLP Analogs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GLP Analogs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GLP Analogs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GLP Analogs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GLP Analogs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GLP Analogs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GLP Analogs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GLP Analogs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GLP Analogs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GLP Analogs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GLP Analogs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GLP Analogs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GLP Analogs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GLP Analogs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GLP Analogs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GLP Analogs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GLP Analogs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GLP Analogs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GLP Analogs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GLP Analogs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GLP Analogs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GLP Analogs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GLP Analogs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GLP Analogs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GLP Analogs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GLP Analogs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GLP Analogs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GLP Analogs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GLP Analogs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GLP Analogs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GLP Analogs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GLP Analogs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GLP Analogs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GLP Analogs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GLP Analogs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GLP Analogs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GLP Analogs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GLP Analogs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GLP Analogs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GLP Analogs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GLP Analogs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GLP Analogs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GLP Analogs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GLP Analogs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GLP Analogs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GLP Analogs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi GLP Analogs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi GLP Analogs Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Eli Lily
  8. 8.2.1 Eli Lily Company Information
  9. 8.2.2 Eli Lily Business Overview
  10. 8.2.3 Eli Lily GLP Analogs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lily GLP Analogs Product Portfolio
  12. 8.2.5 Eli Lily Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK GLP Analogs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GSK GLP Analogs Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca GLP Analogs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca GLP Analogs Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Novo Nordisk
  26. 8.5.1 Novo Nordisk Company Information
  27. 8.5.2 Novo Nordisk Business Overview
  28. 8.5.3 Novo Nordisk GLP Analogs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novo Nordisk GLP Analogs Product Portfolio
  30. 8.5.5 Novo Nordisk Recent Developments
  31. 8.6 Bristol-Myers Squibb
  32. 8.6.1 Bristol-Myers Squibb Company Information
  33. 8.6.2 Bristol-Myers Squibb Business Overview
  34. 8.6.3 Bristol-Myers Squibb GLP Analogs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bristol-Myers Squibb GLP Analogs Product Portfolio
  36. 8.6.5 Bristol-Myers Squibb Recent Developments
  37. 8.7 Amylin
  38. 8.7.1 Amylin Company Information
  39. 8.7.2 Amylin Business Overview
  40. 8.7.3 Amylin GLP Analogs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Amylin GLP Analogs Product Portfolio
  42. 8.7.5 Amylin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GLP Analogs Value Chain Analysis
  2. 9.1.1 GLP Analogs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GLP Analogs Sales Mode & Process
  6. 9.2 GLP Analogs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GLP Analogs Distributors
  9. 9.2.3 GLP Analogs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst